14

Feb2022

Reminder: Form 3 filing is due to the PMPRB On March 1, 2022

This is a reminder to patentees of their filing requirements respecting revenues and development expenditures. These filing requirements are contained in section 5 of the Patented Medicines Regulations. The Annual Form 3 filing to the PMPRB is due on March 1, 2022. As ... Read More

31

Jan2022

Updates to the Ontario Guidelines for Drug Submission and Evaluation

The Ontario Ministry of Health has recently updated the Ontario Guidelines for Drug Submission and Evaluation (Guidelines). In an effort to reduce complexity and simplify their policy document, specific guidelines aiming to address individual product types are now available on the Ontario Ministry of Health website.... Read More

14

Jan2022

REGISTER NOW for PDCI’s Webinar: Impact and Implications of the Delayed Regulations and PMPRB Guidelines

Join us on January 25, 2022 for insights and guidance on the potential impact of delayed PMPRB Pricing Regulations and Guidelines. Health Canada’s announcement on December 23, 2021 delayed the coming into force date for the Patented Medicines Regulations by a further ... Read More

31

Dec2021

PDCI Year in Review

As 2021 comes to an end, PDCI is reflecting on the year we've had in Canadian market access. PDCI's 2021 Year in Review highlights important milestones that occurred in 2021 and looks forward at Trends to Watch in 2022. Click here for the PDF version... Read More

28

Dec2021

Further Delay to the PMPRB Guidelines and amended Regulations

Health Canada announced on December 23, 2021 that the coming into force of the Patented Medicines Regulations has been delayed for another 6 months to July 1, 2022. As a result, implementation of the New PMPRB Guidelines (which in part rely on the amended Regulations) are also delayed until July ... Read More

17

Dec2021

PDCI’s 2021 Census of Insurers

PDCI is pleased to announce the release of the 2021 update to the Census of Insurers. The Census of Insurers is available exclusively through the PDCI Market Access Toolkit. PDCI’s Census of Insurers estimates the market share and private covered lives by insurer across Canada. Private payer and access managers ... Read More

17

Dec2021

New PDCI Market Access INSIGHTS Volume 2, Issue 1

PDCI releases new issue of PDCI Market Access INSIGHTS, featuring research and opinion on the evolving state of private health insurance in Canada. VOLUME 2, ISSUE 1... Read More

17

Dec2021

PMPRB Proposed Amendments to the July 1, 2021 Guidelines

On October 28th, 2021, PMPRB provided their first update to the Notice & Comment that was issued on July 15, 2021. The primary takeaway is PMPRB will be providing patentees two reporting periods for compliance, a change from PMPRB's earlier position expecting one reporting period for ... Read More

17

Dec2021

Consultation Notice: Proposed Framework for a Potential Pan-Canadian Formulary

Consultation on the Proposed Framework for a Potential Pan-Canadian Formulary will be open for feedback from January 11 - February 25, 2022.  A discussion paper summarizing the Advisory Panel’s interim recommendations and proposed process will be posted on the CADTH website and CADTH will host an information session on January 18, 2022 at 1 p.m. (ET).  ... Read More

17

Dec2021

CADTH Pharmaceutical Reviews Update- Issue 27

On December 16, 2021, CADTH provided an update regarding CADTH’s drug review programs. A. Expanded Provisional Funding Algorithm Process CADTH has expanded the provisional funding algorithm process to include a new rapid algorithm process. This rapid algorithm process will be ... Read More